Stay Informed:

COVID-19 (coronavirus) information
Zoom Links: Zoom Help | Teaching with Zoom | Zoom Quick Guide

BME 280B Seminar Series

Speaker Name: 
Robert L. Coffman, Ph.D
Speaker Title: 
Senior VP and Chief Scientific Officer of Dynavax Technologies Corporation in Berkeley, CA
Speaker Organization: 
UCSC Adjunct Prof, BME, DNAX Research Institute, National Academy of Sciences, American Academy of Microbiology
Start Time: 
Thursday, February 7, 2019 - 11:40am
End Time: 
Thursday, February 7, 2019 - 1:15pm
Biomed 200
Josh Stuart
 Title: "Harnessing innate immunity for immune therapy of cancer"
Robert L. Coffman, PhD, is Senior Vice President and Chief Scientific Officer of Dynavax Technologies Corporation in Berkeley, CA and an Adjunct Professor in the Department of Biomolecular Engineering at UCSC. Prior to joining Dynavax in 2000, Dr. Coffman was a founding member of the DNAX Research Institute in Palo Alto, CA. Dr. Coffman has authored over 200 scientific publications, is a member of the National Academy of Sciences and the American Academy of Microbiology, and has received a number of prestigious awards for his work. With colleague Dr. Tim Mosmann, he defined the two principal subtypes of helper T cells, termed Th1 and
Th2 cells, and demonstrated the central relationship between their differences in cytokine expression and function. Dr .Coffman defined basic mechanisms of T-cell regulation in asthma and infectious and parasitic diseases, and demonstrated the central role of regulatory CD4+ T cells in preventing inflammatory bowel disease. At Dynavax, Dr. Coffman has pioneered the development of agonists and antagonists for Toll-like receptors, key recognition receptors in innate immunity.


Thank you to Dovetail Genomics and BSOE for providing sponsorship for the pizzas served at today's Seminar!